Metabolic reprogramming of peritoneal mesothelial cells in peritoneal dialysis–associated fibrosis: therapeutic targets and strategies
Abstract Peritoneal dialysis (PD) is considered a life-saving treatment for end-stage renal disease. However, prolonged PD use can lead to the development of peritoneal fibrosis (PF), diminishing its efficacy. Peritoneal mesothelial cells (PMCs) are key initiators of PF when they become damaged. Exp...
Saved in:
| Main Authors: | Fang Yu, Jia Chen, Xiaoyue Wang, Shihui Hou, Hong Li, Yaru Yao, Yani He, Kehong Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Cell Communication and Signaling |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12964-025-02113-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Potential of Oligo-Fucoidan in Mitigating Peritoneal Dialysis-Associated Fibrosis
by: Yu-Wei Chen, et al.
Published: (2024-11-01) -
Expression and significance of miR-200c in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients
by: ZHANG Lin, et al.
Published: (2018-01-01) -
Research advances of endothelial-mesenchymal transition during peritoneal dialysis-related peritoneal fibrosis
by: Liao Meng, et al.
Published: (2021-01-01) -
Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho
by: Qinglian Wang, et al.
Published: (2023-12-01) -
Research progress of endoplasmic reticulum stress in peritoneal dialysis
by: Li Yan-ling, et al.
Published: (2025-01-01)